Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Linked in and up to speed.
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Education protects against cognitive changes associated with multiple sclerosis.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
Neutrophils Mediate Blood-Spinal Cord Barrier Disruption in Demyelinating Neuroinflammatory Diseases.
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
[Tumefactive multiple sclerosis and connexin].
Patient-reported outcomes in multiple sclerosis: Relationships among existing scales and the development of a brief measure.
Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse.
Intraspinal transplantation of mouse and human neural precursor cells.
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.
Progressive multifocal leukoencephalopathy in multiple sclerosis.
The pathology of an autoimmune astrocytopathy: lessons learned from neuromyelitis optica.
[Indexes of integrative activity of motor system in norm and at neuromotor pathology].
Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Artificial antigen presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells.
Specific Contactin N-glycans are implicated in Neurofascin binding and autoimmune targeting in peripheral neuropathies.
Recurrent paraparesis and death of a patient with 'whippet' abuse.
Role of socioeconomic position in multiple sclerosis etiology.
Impact of electroacupuncture on quality of life for patients with Relapsing-Remitting Multiple Sclerosis under treatment with immunomodulators: A randomized study.
Muscle oxygen consumption by NIRS and mobility in multiple sclerosis patients.
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases.
Pages
« first
‹ previous
…
506
507
508
509
510
511
512
513
514
…
next ›
last »